Anti-inflammatory and antipyretic analgesics and drugs used in gout
The Side Effects of Drugs Annuals form a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the January 2012 to June 2013 publications on adverse reactions to anti-inflammatory and antipyretic analgesics and drugs used in gout covers metamizole, paracetamol (acetaminophen), nonsteroidal anti-inflammatory drugs (the anthranilic acid derivative mefenamic acid, the arylalkanoic acid derivatives bufexamac, diclofenac, ibuprofen, and ketorolac, the COX-2 selective inhibitors celecoxib, etoricoxib, rofecoxib, the oxicam, meloxicam, and the pyrazolone derivative phenylbutazone), acetylsalicylic acid (aspirin), benzydamine (benzindamine), nefopam, and drugs used in the treatment of gout (allopurinol, colchicine, febuxostat and rasburicase).
|Acetaminophen, Acetylsalicylic acid, ADAM33, Adenosine receptors, Adverse drug reactions, Allopurinol, Anthranilic acid derivatives, Arylalkanoic acid derivatives, Aspirin, Benzindamine, Benzydamine, Bufexamac, Celecoxib, Chemokine CC motif receptors, Colchicine, Complement, COX-2 selective inhibitors, Coxibs, CYP isoenzymes, Diclofenac, Dipyrone, EMID2, Etoricoxib, FANCC, Febuxostat, G protein signalling, Growth factors, HLA, Ibuprofen, Indoleamine-pyrrole 2,3 dioxygenase, Interleukins, Ketorolac, Kinesin, Leukotrienes, Mefenamic acid, Meloxicam, Metamizole, MS4A2, N-acetyl transferase-2, N-methyl d-aspartate receptors, Nefopam, Nonsteroidal anti-inflammatory drugs, Oxicams, Paracetamol, Phenylbutazone, Prostaglandin receptors, Purinergic receptors, Pyrazolone derivatives, Rasburicase, Renin-angiotensin system, Rofecoxib, Thromboxanes, Transporters, Tumour necrosis factor-α|
|Organisation||Department of Medical Informatics|
Masclee, G.M.C. (2014). Anti-inflammatory and antipyretic analgesics and drugs used in gout. doi:10.1016/B978-0-444-63407-8.00009-5